| Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and Therapy (NCT04334096) | Tumor Center Regensburg | 2016-05-30 |
| Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria (NCT02733601) | AstraZeneca | 2016-05-29 |
| Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients (NCT03376503) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2016-05-25 |
| Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel (NCT01821833) | New Mexico Cancer Research Alliance | 2016-05-24 |
| Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) (NCT02764541) | Dana-Farber Cancer Institute | 2016-05-24 |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer (NCT02750358) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation (NCT02783690) | Mayo Clinic | 2016-05-18 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| Health Belief Model Based Nursing Interventions on Lymphedema Prevention (NCT04098783) | Ayse Cal | 2016-05-15 |
| Breast Aesthetics by Three Dimensional Measures (NCT03578484) | Sykehuset Telemark | 2016-05-13 |
| Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients (NCT02772367) | Memorial Sloan Kettering Cancer Center | 2016-05-11 |
| Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance (NCT02767986) | National Human Genome Research Institute (NHGRI) | 2016-05-10 |
| A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors (NCT04476641) | Sun Yat-sen University | 2016-05-06 |
| STOP Heart Disease in Breast Cancer Survivors Trial (NCT02674204) | Cedars-Sinai Medical Center | 2016-05-05 |
| The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia (NCT02761460) | wang shusen | 2016-05-04 |
| Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (NCT02637024) | Ontario Clinical Oncology Group (OCOG) | 2016-05-01 |
| Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients (NCT02790580) | National University Hospital, Singapore | 2016-05-01 |
| Increasing Physical Activity Among Breast Cancer Survivors With Depression (NCT02781051) | University of Texas Southwestern Medical Center | 2016-05-01 |
| A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer (NCT02637375) | University of Chicago | 2016-05-01 |
| Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006) (NCT02878057) | Peking University Cancer Hospital & Institute | 2016-05-01 |
| A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery (NCT03109990) | RenJi Hospital | 2016-05-01 |
| APBI: 27Gy in 5 Fractions for Early Breast Cancer (NCT02681107) | AHS Cancer Control Alberta | 2016-05-01 |
| Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness (NCT02844504) | Kessler Foundation | 2016-05-01 |
| Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation (NCT02729701) | University of Kansas Medical Center | 2016-05-01 |
| Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers (NCT02701348) | NHS Tayside | 2016-05-01 |
| Breast Cancer Lung Late Effects (NCT02725840) | University of Florida | 2016-05-01 |
| Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In (NCT02708680) | Syndax Pharmaceuticals | 2016-05-01 |
| Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis (NCT02810093) | University Hospital, Strasbourg, France | 2016-05-01 |
| Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer (NCT02777164) | Real Imaging Ltd. | 2016-05-01 |
| Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer (NCT03150576) | Cambridge University Hospitals NHS Foundation Trust | 2016-05-01 |
| Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients (NCT03541161) | Samsung Medical Center | 2016-05-01 |
| Pregnant Exposure to Persistent Organic Pollutants (NCT03419026) | Centre Hospitalier Universitaire de Nice | 2016-05-01 |
| Association of Capecitabine Pharmacokinetics and Toxicity With Aging (NCT03465202) | Newcastle-upon-Tyne Hospitals NHS Trust | 2016-05-01 |
| Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries (NCT02736604) | Tata Memorial Hospital | 2016-05-01 |
| A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities (NCT02783755) | Duke University | 2016-05-01 |
| Clinical Application of CTDNA in Operable Breast Cancer Patients (NCT02797652) | Peking Union Medical College Hospital | 2016-05-01 |
| Using BETTER Model Sexual Problems in Breast Cancer (NCT04297657) | Istanbul University - Cerrahpasa | 2016-04-28 |
| A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects (NCT02742935) | Jiangsu HengRui Medicine Co., Ltd. | 2016-04-27 |
| Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy (NCT02752009) | Dana-Farber Cancer Institute | 2016-04-26 |
| GISEL:Registry of Breast Cancer Patients Treated With ECT (NCT06683404) | Istituto Oncologico Veneto IRCCS | 2016-04-22 |
| Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing (NCT04929197) | Taipei Medical University Hospital | 2016-04-21 |
| Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy (NCT02753673) | Memorial Sloan Kettering Cancer Center | 2016-04-20 |
| Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer (NCT02657889) | Tesaro, Inc. | 2016-04-15 |
| PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial (NCT02624973) | Haukeland University Hospital | 2016-04-15 |
| A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy (NCT02935920) | Vejle Hospital | 2016-04-11 |
| Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer (NCT02630693) | Canadian Cancer Trials Group | 2016-04-08 |
| Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial (NCT02603341) | Abramson Cancer Center at Penn Medicine | 2016-04-06 |
| PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer (NCT02732171) | Abramson Cancer Center at Penn Medicine | 2016-04-01 |
| REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab (NCT02688998) | Ottawa Hospital Research Institute | 2016-04-01 |
| Diffusion Tensor Breast MRI (DTI) (NCT02812589) | University Health Network, Toronto | 2016-04-01 |
| Physiotherapy in Women With Peripheral Persistent Pain Following Breast Cancer Treatment (NCT02735668) | University of Alcala | 2016-04-01 |
| Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects (NCT02538484) | The University of Texas Health Science Center at San Antonio | 2016-04-01 |
| Imaging the Patterns of Breast Cancer Early Metastases (NCT02706964) | University of Florida | 2016-04-01 |
| Exercise Preconditioning and Breast Cancer Cardiotoxicity (NCT02842658) | Mayo Clinic | 2016-04-01 |
| Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment? (NCT03286257) | Liverpool John Moores University | 2016-04-01 |
| Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema (NCT02726477) | Fourth Affiliated Hospital of Guangxi Medical University | 2016-04-01 |
| Pink Warrior-Support Group Toolkit for Breast Cancer Survivors (NCT02750241) | The University of Texas Medical Branch, Galveston | 2016-04-01 |
| Indocyanine Green Fluorescence-guided Sentinel Node Biopsy in Breast Cancer Within a North African Population: a Retrospective Study (NCT04879680) | Faculty of Medicine, Sousse | 2016-04-01 |
| Lymphedema Surveillance Study (NCT02743858) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer (NCT02593227) | Marker Therapeutics, Inc. | 2016-04-01 |
| Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer (NCT02921152) | Acibadem University | 2016-04-01 |
| Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients (NCT02694224) | Clinica Universidad de Navarra, Universidad de Navarra | 2016-04-01 |
| Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. (NCT02651844) | Hospital Provincial Magdalena V. de Martínez | 2016-04-01 |
| Exercise Program in Cancer and Cognition (NCT02793921) | University of Pittsburgh | 2016-04-01 |
| PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer (NCT03006614) | Shi Yanxia | 2016-04-01 |
| Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment. (NCT02632435) | Ottawa Hospital Research Institute | 2016-04-01 |
| Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women (NCT02914158) | First Affiliated Hospital, Sun Yat-Sen University | 2016-03-30 |
| Use of Compressed Sensing in Breast MRI (NCT02826369) | Institut de Cancérologie de Lorraine | 2016-03-29 |
| CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER (NCT03712956) | European Institute of Oncology | 2016-03-25 |
| Does Intra-operative MarginProbe Use Reduce Re-excision Rates? (NCT02774785) | Manchester University NHS Foundation Trust | 2016-03-22 |
| Contrast Enhanced Spectral Mammography (CESM) Study (NCT02479100) | Cambridge University Hospitals NHS Foundation Trust | 2016-03-22 |
| Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer (NCT02712437) | University of Michigan Rogel Cancer Center | 2016-03-16 |
| Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients (NCT02831530) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-03-16 |
| Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors (NCT02763228) | Case Comprehensive Cancer Center | 2016-03-16 |
| Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel (NCT02586025) | Hoffmann-La Roche | 2016-03-14 |
| Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon (NCT02844608) | Centre Hospitalier Universitaire de Besancon | 2016-03-10 |
| Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer (NCT02679755) | Pfizer | 2016-03-09 |
| An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. (NCT02657343) | Dana-Farber Cancer Institute | 2016-03-09 |
| Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors (NCT02786797) | University of South Florida | 2016-03-07 |
| Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients (NCT03350854) | University of Utah | 2016-03-07 |
| A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany (NCT02666261) | Hoffmann-La Roche | 2016-03-04 |
| Guangzhou Women's Health Cohort Study (GWHCS) (NCT05506800) | Guangzhou Women and Children's Medical Center | 2016-03-03 |
| Risk Assessment Tool in Saudi Arabia (NCT02781116) | National Guard Health Affairs | 2016-03-01 |
| Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX) (NCT03371732) | Institut Bergonié | 2016-03-01 |
| Whole-body MRI for the Detection of Metastasis (NCT02183597) | Norwegian University of Science and Technology | 2016-03-01 |
| A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer (NCT02685306) | Peregrine Pharmaceuticals | 2016-03-01 |
| The Frequency of Thyroid Diseases in Women With Breast Cancer (NCT04406779) | Uşak University | 2016-03-01 |
| Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia (NCT02692742) | Myelo Therapeutics GmbH | 2016-03-01 |
| Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program (NCT02585362) | Kantonsspital Winterthur KSW | 2016-03-01 |
| Hybrid Gamma Camera in Breast Surgery (NCT02621099) | University of Nottingham | 2016-03-01 |
| Overall Survival and Disease-free Survival in Breast Cancer Patients Under COS (NCT02745262) | IVI Vigo | 2016-03-01 |
| Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake (NCT02517593) | Mayo Clinic | 2016-03-01 |
| A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast Cancer (NCT02817334) | National Cancer Center, Korea | 2016-03-01 |
| Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients (NCT02532400) | Ruijin Hospital | 2016-03-01 |
| ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) (NCT02546934) | Fudan University | 2016-03-01 |
| Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer (NCT02567929) | Konkuk University Medical Center | 2016-03-01 |
| Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer (NCT02725541) | Jenny C. Chang, MD | 2016-03-01 |
| A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer (NCT02713984) | Zhi Yang | 2016-03-01 |
| uPAR PET/CT for Preoperative Staging of Breast Cancer Patients (NCT02681640) | Rigshospitalet, Denmark | 2016-03-01 |
| Effect of Mechanical Stimulation on Mastectomy Scars (NCT02702050) | The Queen Elizabeth Hospital | 2016-03-01 |